{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T01:27:02Z","timestamp":1767835622555,"version":"3.49.0"},"reference-count":29,"publisher":"American Diabetes Association","issue":"2","license":[{"start":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T00:00:00Z","timestamp":1579478400000},"content-version":"vor","delay-in-days":39,"URL":"http:\/\/www.diabetesjournals.org\/content\/license"}],"funder":[{"name":"Andalusian Society of Endocrinology, Diabetes, and Nutrition"}],"content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,2,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>To assess the impact of a telemedicine visit using the platform Diabetic compared with a face-to-face visit on clinical outcomes, patients\u2019 health-related quality of life (HRQoL), and physicians\u2019 satisfaction in patients with type 1 diabetes.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>PLATEDIAN (Telemedicine on Metabolic Control in Type 1 Diabetes Mellitus Andalusian Patients) (NCT03332472) was a multicenter, randomized, 6-month follow-up, open-label, parallel-group controlled study performed in patients with type 1 diabetes with suboptimal metabolic control (HbA1c &amp;lt;8% [&amp;lt;64 mmol\/mol]), treated with multiple daily injections. A total of 388 patients were assessed for eligibility; 379 of them were randomized 1:1 to three face-to-face visits (control cohort [CC]) (n = 167) or the replacement of an intermediate face-to-face visit by a telemedicine visit using Diabetic (intervention cohort [IC]) (n = 163). The primary efficacy end point was the mean change of HbA1c levels from baseline to month 6. Other efficacy and safety end points were mean blood glucose, glucose variability, episodes of hypoglycemia and hyperglycemia, patient-reported outcomes, and physicians\u2019 satisfaction.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>At month 6, the mean change in HbA1c levels was \u22120.04 \u00b1 0.5% (\u22120.5 \u00b1 5.8 mmol\/mol) in the CC and 0.01 \u00b1 0.6% (0.1 \u00b1 6.0 mmol\/mol) in the IC (P = 0.4941). The number of patients who achieved HbA1c &amp;lt;7% (&amp;lt;53 mmol\/mol) was 73 and 78 in the CC and IC, respectively. Significant differences were not found regarding safety end points at 6 months. Changes in HRQoL between the first visit and final visit did not differ between cohorts, and, regarding fear of hypoglycemia (FH-15 score \u226528), statistically significant differences observed at baseline remained unchanged at 6 months (P &amp;lt; 0.05).<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>The use of telemedicine in patients with type 1 diabetes with HbA1c &amp;lt;8% (&amp;lt;64 mmol\/mol) provides similar efficacy and safety outcomes as face-to-face visits.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc19-0739","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T22:15:12Z","timestamp":1576188912000},"page":"337-342","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":48,"title":["Randomized Study to Evaluate the Impact of Telemedicine Care in Patients With Type 1 Diabetes With Multiple Doses of Insulin and Suboptimal HbA1c in Andalusia (Spain): PLATEDIAN Study"],"prefix":"10.2337","volume":"43","clinical-trial-number":[{"clinical-trial-number":"nct03332472","registry":"10.18810\/clinical-trials-gov","type":"results"}],"author":[{"given":"Maria S.","family":"Ruiz de Adana","sequence":"first","affiliation":[{"name":"Endocrinology and Nutrition Department, Hospital Regional Universitario de M\u00e1laga, M\u00e1laga, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), M\u00e1laga, Spain"},{"name":"Ciber de Diabetes y Enfermedades Metab\u00f3licas (CIBERDEM), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosa","family":"Alhambra-Exp\u00f3sito","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Department, Hospital Universitario Reina Sof\u00eda, C\u00f3rdoba, Spain"},{"name":"Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), C\u00f3rdoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Araceli","family":"Mu\u00f1oz-Garach","sequence":"additional","affiliation":[{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), M\u00e1laga, Spain"},{"name":"Endocrinology and Nutrition Department, Hospital Universitario Virgen de la Victoria, M\u00e1laga, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Gonzalez-Molero","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Department, Hospital Regional Universitario de M\u00e1laga, M\u00e1laga, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), M\u00e1laga, Spain"},{"name":"Ciber de Diabetes y Enfermedades Metab\u00f3licas (CIBERDEM), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3259-3336","authenticated-orcid":false,"given":"Natalia","family":"Colomo","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Department, Hospital Regional Universitario de M\u00e1laga, M\u00e1laga, Spain"},{"name":"Instituto de Investigaci\u00f3n Biom\u00e9dica de M\u00e1laga (IBIMA), M\u00e1laga, Spain"},{"name":"Ciber de Diabetes y Enfermedades Metab\u00f3licas (CIBERDEM), Madrid, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabel","family":"Torres-Barea","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Department, Hospital Universitario de Jerez, Jerez, C\u00e1diz, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Aguilar-Diosdado","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Department, Hospital Universitario Puerta del Mar, C\u00e1diz, Spain"},{"name":"Biomedical Institute of Research of Cadiz (INIBICA), Cadiz, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentino","family":"Carral","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Department, Hospital Universitario Puerto Real, Puerto Real, C\u00e1diz, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuel","family":"Serrano","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Department, Complejo Hospitalario de Ja\u00e9n, Ja\u00e9n, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria A.","family":"Mart\u00ednez-Brocca","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Department, Hospital Universitario Virgen Macarena, Sevilla, Spain"},{"name":"Instituto de Biomedicina de Sevilla (IBiS), Hospital Universitario Virgen del Roc\u00edo\/Consejo Superior de Investigaciones Cient\u00edficas\/Universidad de Sevilla, Sevilla, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Duran","sequence":"additional","affiliation":[{"name":"Medical Department, Sanofi Spain, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Palomares","sequence":"additional","affiliation":[{"name":"Endocrinology and Nutrition Department, Hospital Universitario Reina Sof\u00eda, C\u00f3rdoba, Spain"},{"name":"Maimonides Institute of Biomedical Research of Cordoba (IMIBIC), C\u00f3rdoba, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","published-online":{"date-parts":[[2019,12,12]]},"reference":[{"key":"2022031300004626200_B1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.2337\/dc18-Sint01","article-title":"Standards of Medical Care in Diabetes\u20142018","volume":"41","author":"American Diabetes Association","year":"2018","journal-title":"Diabetes Care"},{"key":"2022031300004626200_B2","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.semerg.2016.06.004","article-title":"Health status, quality of life, and use of healthcare resources by patients with diabetes mellitus in Spain","volume":"43","author":"Garc\u00eda-Soid\u00e1n","year":"2017","journal-title":"Semergen"},{"key":"2022031300004626200_B3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00592-017-0963-4","article-title":"Young patients with type 1 diabetes poorly controlled and poorly compliant with self-monitoring of blood glucose: can technology help? Results of the i-NewTrend randomized clinical trial","volume":"54","author":"Di Bartolo","year":"2017","journal-title":"Acta Diabetol"},{"key":"2022031300004626200_B4","first-page":"S1","article-title":"Standards of Medical Care in Diabetes\u20142017","volume":"40","author":"American Diabetes Association","year":"2017","journal-title":"Diabetes Care"},{"key":"2022031300004626200_B5","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"2022031300004626200_B6","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jcjd.2016.06.001","article-title":"Improved A1C levels in type 1 diabetes with smartphone app use","volume":"41","author":"Ryan","year":"2017","journal-title":"Can J Diabetes"},{"key":"2022031300004626200_B7","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2337\/dc10-1259","article-title":"The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 Study)","volume":"34","author":"Charpentier","year":"2011","journal-title":"Diabetes Care"},{"key":"2022031300004626200_B8","volume-title":"Telemedicine: Opportunities and Developments in Member States: Report on the Second Global Survey on eHealth 2009","author":"World Health Organization","year":"2010"},{"key":"2022031300004626200_B9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/MBP.0b013e328346e092","article-title":"Telecare is a valuable tool for hypertension management, a systematic review and meta-analysis","volume":"16","author":"Verberk","year":"2011","journal-title":"Blood Press Monit"},{"key":"2022031300004626200_B10","first-page":"CD007718","article-title":"Telehealthcare for chronic obstructive pulmonary disease","volume":"6","author":"Mclean","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2022031300004626200_B11","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1177\/193229681200600301","article-title":"Improved outcomes from diabetes monitoring: the benefits of better adherence, therapy adjustments, patient education, and telemedicine support","volume":"6","author":"Klonoff","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"2022031300004626200_B12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2337\/dc09-1327","article-title":"Diabetes Interactive Diary: a new telemedicine system enabling flexible diet and insulin therapy while improving quality of life: an open-label, international, multicenter, randomized study","volume":"33","author":"Rossi","year":"2010","journal-title":"Diabetes Care"},{"key":"2022031300004626200_B13","doi-asserted-by":"crossref","first-page":"E341","DOI":"10.1503\/cmaj.150885","article-title":"Effect of telemedicine on glycated hemoglobin in diabetes: a systematic review and meta-analysis of randomized trials","volume":"189","author":"Faruque","year":"2017","journal-title":"CMAJ"},{"key":"2022031300004626200_B14","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1089\/tmj.2018.0128","article-title":"Clinical effectiveness of telemedicine in diabetes mellitus: a meta-analysis of 42 randomized controlled trials","volume":"25","author":"Tchero","year":"2019","journal-title":"Telemed J E Health"},{"key":"2022031300004626200_B15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.3389\/fphar.2017.00330","article-title":"Telemedicine for the management of glycemic control and clinical outcomes of type 1 diabetes mellitus: a systematic review and meta-analysis of randomized controlled studies","volume":"8","author":"Lee","year":"2017","journal-title":"Front Pharmacol"},{"key":"2022031300004626200_B16","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.5888\/pcd15.170168","article-title":"Telemedicine in the management of type 1 diabetes","volume":"15","author":"Xu","year":"2018","journal-title":"Prev Chronic Dis"},{"key":"2022031300004626200_B17","first-page":"435","article-title":"The efficiency of telemedicine to optimize metabolic sontrol in patients with type 1 diabetes mellitus: telemed study","volume-title":"Diabetes Technol Ther","author":"Esmatjes","year":"2014"},{"key":"2022031300004626200_B18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1089\/dia.2015.0123","article-title":"Use of telemedicine to improve adherence to American Diabetes Association standards in pediatric type 1 diabetes","volume":"18","author":"Wood","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"2022031300004626200_B19","first-page":"1","volume-title":"Guideline for Good Clinical Practice E6(R2)","author":"European Medicines Agency","year":"2016"},{"key":"2022031300004626200_B20","unstructured":"World Medical Association General Assembly. Declaration of Helsinki: ethical principles for medical research involving human subjects [article online], 1964. Available from https:\/\/www.wma.net\/wp-content\/uploads\/2018\/07\/DoH-Jun1964.pdf. Accessed 5 May 2019"},{"key":"2022031300004626200_B21","first-page":"349","article-title":"Web-based telemedicine system is useful for monitoring glucose control in pregnant women with diabetes","volume-title":"Diabetes Technol Ther","author":"Carral","year":"2015"},{"key":"2022031300004626200_B22","doi-asserted-by":"crossref","first-page":"41","DOI":"10.2337\/diaspect.17.1.41","article-title":"Development and validation of the diabetes quality of life brief clinical inventory","volume":"17","author":"Burroughs","year":"2004","journal-title":"Diabetes Spectr"},{"key":"2022031300004626200_B23","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/dme.12887","article-title":"How to assess diabetes distress: comparison of the Problem Areas in Diabetes Scale (PAID) and the Diabetes Distress Scale (DDS)","volume":"33","author":"Schmitt","year":"2016","journal-title":"Diabet Med"},{"key":"2022031300004626200_B24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1037\/a0021927","article-title":"Development of a new fear of hypoglycemia scale: FH-15","volume":"23","author":"Anarte Ortiz","year":"2011","journal-title":"Psychol Assess"},{"key":"2022031300004626200_B25","first-page":"1","article-title":"High inflammatory markers in subjects with type 1 diabetes and its relationship with diabetes-related complications and insulin treatment","volume":"28","author":"Ruiz de Adana","year":"2012","journal-title":"Av Diabetol"},{"key":"2022031300004626200_B26","volume-title":"Stata Statistical Software: Release 14","author":"StataCorp","year":"2015"},{"key":"2022031300004626200_B27","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/1357633X17704346","article-title":"Telemedicine consultation for patients with diabetes mellitus: a cluster randomised controlled trial","volume":"24","author":"Sood","year":"2018","journal-title":"J Telemed Telecare"},{"key":"2022031300004626200_B28","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1097\/MD.0000000000000312","article-title":"Clinical- and cost-effectiveness of telemedicine in type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"93","author":"Zhai","year":"2014","journal-title":"Medicine (Baltimore)"},{"key":"2022031300004626200_B29","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.diabet.2007.12.002","article-title":"High day-to-day glucose variability: a frequent phenomenon in children and adolescents with type 1 diabetes attending summer camp","volume":"34","author":"Choleau","year":"2008","journal-title":"Diabetes Metab"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/care.diabetesjournals.org\/syndication\/doi\/10.2337\/dc19-0739","content-type":"unspecified","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/2\/337\/531040\/dc190739.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/43\/2\/337\/531040\/dc190739.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T22:00:40Z","timestamp":1647122440000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/43\/2\/337\/36029\/Randomized-Study-to-Evaluate-the-Impact-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,12]]},"references-count":29,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2019,12,12]]},"published-print":{"date-parts":[[2020,2,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc19-0739","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,12,12]]}}}